Daniel Lasserson

InstitutionUniversity of Birmingham
AddressBirmingham
United Kingdom
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 7 Covid-19 publications, with a maximum of 2 publications in August 2021
    All Publications
    Bar chart showing 58 publications over 17 distinct years, with a maximum of 10 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Micocci M, Gordon AL, Seo MK, Allen AJ, Davies K, Lasserson D, Thompson C, Spilsbury K, Akrill C, Heath R, Astle A, Sharpe C, Perera R, Hayward G, Buckle P. Is point-of-care testing feasible and safe in care homes in England? An exploratory usability and accuracy evaluation of a point-of-care polymerase chain reaction test for SARS-CoV-2. Age Ageing. 2021 09 11; 50(5):1464-1472. PMID: 33884411.
      Citations: 1     Fields:    Translation:Humans
    2. Zaman I, Beevers ZCR, Ahmed R, Lasserson D, Knight T. NEWS2 to assess suspected COVID-19 in the community: a service evaluation of a primary care assessment centre. Fam Pract. 2021 Aug 27; 38(Suppl 1):i3-i8. PMID: 34448485.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Goyal DK, Mansab F, Naasan AP, Iqbal A, Millar C, Franklin G, Thomas S, McFadden J, Burke D, Lasserson D. Restricted access to the NHS during the COVID-19 pandemic: Is it time to move away from the rationed clinical response? Lancet Reg Health Eur. 2021 Sep; 8:100201. PMID: 34423329.
      Citations:    
    4. Hinks TSC, Cureton L, Knight R, Wang A, Cane JL, Barber VS, Black J, Dutton SJ, Melhorn J, Jabeen M, Moss P, Garlapati R, Baron T, Johnson G, Cantle F, Clarke D, Elkhodair S, Underwood J, Lasserson D, Pavord ID, Morgan S, Richards D. Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial. Lancet Respir Med. 2021 10; 9(10):1130-1140. PMID: 34252378.
      Citations: 7     Fields:    Translation:Humans
    5. Nicodemo C, Barzin S, Cavalli N, Lasserson D, Moscone F, Redding S, Shaikh M. Measuring geographical disparities in England at the time of COVID-19: results using a composite indicator of population vulnerability. BMJ Open. 2020 09 29; 10(9):e039749. PMID: 32994257.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    6. Hinks TSC, Barber VS, Black J, Dutton SJ, Jabeen M, Melhorn J, Rahman NM, Richards D, Lasserson D, Pavord ID, Bafadhel M. A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial. Trials. 2020 Aug 17; 21(1):718. PMID: 32807209.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    7. Knight T, Edwards L, Rajasekaran A, Clare S, Lasserson D. Point-of-care lung ultrasound in the assessment of suspected COVID-19: a retrospective service evaluation with a severity score. Acute Med. 2020; 19(4):192-200. PMID: 33215172.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health